PECAM-1 and junctional adhesion molecules act at endothelial cell contacts where an adherent leukocyte engages the vascular junction. Their participation helps coordinate the interaction between the leukocyte and neighboring endothelial cells as a passage forms. This junctional signaling is important because it links immune-cell adhesion with the localized opening required for movement into inflamed or infected tissue.
Actin remodeling allows both the leukocyte and the endothelial barrier to adjust their shapes during passage. At the same time, endothelial junctions loosen temporarily rather than remaining permanently disrupted. Coordinating cytoskeletal movement with reversible junctional changes creates a controlled route through the vascular wall, helping immune cells exit efficiently while limiting unnecessary loss of barrier organization.
Adhesion positions the leukocyte at the endothelial surface and enables interactions with junctional molecules, including PECAM-1 and junctional adhesion molecules. This localized contact precedes cytoskeletal remodeling and temporary junctional loosening. Without the initial attachment step, the later events would not be spatially coordinated with an endothelial cell boundary, reducing the ability of the cell to enter tissue at the appropriate site.
Inflammation and infection create situations in which immune cells must leave the bloodstream and reach damaged tissue or invading pathogens. Paracellular transmigration provides the vascular route for that recruitment, linking endothelial-barrier behavior to host defense. Its activity therefore affects how effectively neutrophils, monocytes, and lymphocytes can be directed from circulation toward sites requiring an immune response.
The sequence begins when a leukocyte adheres to the endothelium. It then engages junctional molecules such as PECAM-1 and junctional adhesion molecules, while actin remodeling changes cell shape and movement. Endothelial junctions loosen temporarily, allowing the leukocyte to pass between adjacent endothelial cells and continue from the bloodstream into the surrounding tissue.
Neutrophils, monocytes, and lymphocytes are identified as important leukocyte populations that use this route toward sites of tissue damage or invading pathogens. Their recruitment supports host defense while reflecting different immune responses within the same vascular process. Studying how these populations cross the endothelial barrier can therefore clarify immune-cell trafficking during inflammation and infection.
The process connects immune-cell recruitment with the regulation of vascular permeability and endothelial-barrier behavior. This makes it relevant not only to immunology and infection, but also to research on inflammatory disease and therapies intended to regulate immune-cell recruitment. Investigators can use this context to examine how junctional interactions and barrier changes influence tissue-directed inflammation.